Roflumilast 0.05% cream, a new once-daily, steroid-free treatment that can be used anywhere on the body, was approved by the Food and Drug Administration to treat mild to moderate atopic dermatitis in children 2 to 5 years of age. According to the manufacturer’s press release, roflumilast can be used for any duration of time, which can be a benefit because the topical steroids that have been a standard treatment are not appropriate for long-term use. …
Read More